What one share of Biotricity holds
Biotricity’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.62 |
|---|---|
| Profit | −$0.13 |
| Cash and investments | $0.02 |
| Debt | $0.10 |
| Book value | −$1.76 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2014 | — | −$0.12 | — | — | — | −$0.23 |
| 2015 | — | −$0.12 | — | — | — | −$0.16 |
| 2015 | — | −$1.42 | — | — | — | −$0.47 |
| 2016 | — | −$1.12 | — | — | — | −$0.97 |
| 2016 | — | −$1.69 | — | — | — | −$1.42 |
| 2017 | — | −$1.81 | — | — | — | −$1.46 |
| 2018 | — | −$1.72 | — | — | — | $0.04 |
| 2019 | $0.07 | −$1.54 | — | — | — | −$0.34 |
| 2020 | $0.24 | −$1.89 | — | — | — | −$0.55 |
| 2021 | $0.54 | −$2.63 | — | — | — | −$1.13 |
| 2022 | $1.01 | −$3.99 | $0.00 | −$2.01 | — | −$0.26 |
| 2023 | $1.11 | −$2.26 | — | — | — | −$2.33 |
| 2024 | $1.34 | −$1.66 | — | — | — | −$3.36 |
| 2025 | $0.64 | −$0.55 | — | — | — | −$1.23 |
| 2026 | $0.59 | −$0.11 | — | — | — | −$1.21 |
Common questions about Biotricity
How much does one share of Biotricity earn?
Over the last 12 months, Biotricity lost $0.13 for each share on $0.62 of sales.
Does Biotricity pay a dividend?
Biotricity didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Biotricity’s book value per share?
Biotricity’s book value is negative (−$1.76 per share): it owes more than everything it owns is recorded at, often after years of buying back its own shares, as of June 30, 2026.
How much cash and debt does each share of Biotricity have?
Each share of Biotricity has $0.02 of cash and investments and $0.10 of debt, as of June 30, 2026.
Has Biotricity bought back shares?
Biotricity’s share count rose about 3541% from 2014 to 2026. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.